XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Feb. 28, 2023
Feb. 28, 2022
Cash Flows (For) From Operating Activities    
Net Income (Loss) $ (28,442) $ 33,348
Adjustments to reconcile net (loss) income to net cash (for) from operating activities:    
Depreciation and amortization 59,938 17,833
Impairment of discontinued product lines 2,300 0
Loss on sale of minority interest 1,516 0
Deferred income taxes (5,299) (720)
Share-based compensation 7,311 5,045
Disposal of property and equipment (472) 0
Financing fee amortization 1,860 0
Change in operating assets and liabilities, net of business acquisitions:    
Accounts receivable (47,535) (883)
Inventories (656) (11,956)
Prepaid expenses and other current assets (31,896) (3,824)
Accounts payable, accruals and other changes (8,422) (5,652)
Change in other non-current assets and non-current liabilities (3,579) 14,457
Interest expense accrual 3,438 0
Net Cash (For) From Operating Activities (49,938) 47,648
Cash Flows From (For) Investing Activities    
Purchases of property, equipment and other non-current intangible assets (40,253) (11,891)
Proceeds from the sale of marketable securities 233,020 284,367
Purchases of marketable securities (12,523) (314,442)
Proceeds from the sale of property and equipment 682 0
Business acquisitions, net of working capital adjustments and cash acquired 13,237 (38,164)
Net Cash From (For) Investing Activities 194,163 (80,130)
Cash Flows (For) From Financing Activities    
Exercise of stock options and issuance of employee stock purchase plan shares 943 7,842
Financing fees paid (19,276) 0
Repayment of debt (100,000) 0
Net Cash (For) From Financing Activities (118,333) 7,842
Effects of Foreign Exchange Rates on Cash (3,231) (8,083)
Net Increase (Decrease) in Cash and Cash Equivalents 22,661 (32,723)
Cash and Cash Equivalents, Beginning of period 44,473 75,602
Cash and Cash Equivalents, End of period $ 67,134 $ 42,879